Rimteravimab (XVR011) is a bivalent VHH-Fc antibody that targets the disease caused by SARS-CoV-2, exhibiting potent neutralizing activity, high stability, broad coverage, and silenced Fc effector functions [1].
CAS Number:
[2540797-21-3]
Target:
SARS-CoV
* VAT and and shipping costs not included. Errors and price changes excepted